Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Diabetes Reports
Published in: Current Diabetes Reports 8/2014

01-08-2014 | Diabetes and Other Diseases-Emerging Associations (JJ Nolan, Section Editor)

Type 1 Diabetes and Celiac Disease: Clinical Overlap and New Insights into Disease Pathogenesis

Authors: Aaron Cohn, Anthony M. Sofia, Sonia S. Kupfer

Published in: Current Diabetes Reports | Issue 8/2014

Login to get access

Abstract

Type 1 diabetes (T1D) and celiac disease (CD) are autoimmune diseases with clinical and pathogenic overlap. The mean prevalence of CD in patients with T1D is about 8 %. Classic intestinal symptoms of CD may not be present in T1D leading to the recommendation for active case finding in this higher risk group. Screening is done with sensitive and specific serologies including tissue transglutaminase (tTG) IgA and deaminated gliadin peptide (DGP) IgA and IgG. Positive serologies are confirmed by the presence of villous atrophy and increased intraepithelial lymphocytes on duodenal biopsy. A strict gluten free diet is recommended, although this can pose challenges for T1D patients who already have dietary restrictions. In aggregate, it appears as if the gluten free diet may help T1D management. T1D and CD have overlapping genetic and environmental risk factors. Among these, non-HLA genetic factors and the gut microbiome are among recent developments that will be discussed in this review.
Literature
1.•
Dabelea D. The accelerating epidemic of childhood diabetes. Lancet. 2009;373:1999–2000. An excellent review on the increasing incidence of type 1 diabetes.PubMedCrossRef
2.
3.•
Kang JY, Kang AH, Green A, Gwee KA, Ho KY. Systematic review: worldwide variation in the frequency of coeliac disease and changes over time. Aliment Pharmacol Ther. 2013;38:226–45. An up-to-date review on celiac disease and worldwide variation.PubMedCrossRef
4.
Dube C, Rostom A, Sy R, Cranney A, Saloojee N, et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology. 2005;128:S57–67.PubMedCrossRef
5.
Gillett PM, Gillett HR, Israel DM, Metzger DL, Stewart L, et al. High prevalence of celiac disease in patients with type 1 diabetes detected by antibodies to endomysium and tissue transglutaminase. Can J Gastroenterol. 2001;15:297–301.PubMed
6.•
Volta U, Tovoli F, Caio G. Clinical and immunological features of celiac disease in patients with Type 1 diabetes mellitus. Expert Rev Gastroenterol Hepatol. 2011;5:479–87. A comprehensive clinical review on celiac disease in patients with type 1 diabetes.PubMedCrossRef
7.
Kaistha A, Castells S. Celiac disease in African American children with type 1 diabetes mellitus in inner city Brooklyn. Pediatr Endocrinol Rev. 2008;5 Suppl 4:994–8.PubMed
8.
Green PH. The many faces of celiac disease: clinical presentation of celiac disease in the adult population. Gastroenterology. 2005;128:S74–8.PubMedCrossRef
9.
Reilly NR, Fasano A, Green PH. Presentation of celiac disease. Gastrointest Endosc Clin N Am. 2012;22:613–21.PubMedCrossRef
10.
Freemark M, Levitsky LL. Screening for celiac disease in children with type 1 diabetes: two views of the controversy. Diabetes Care. 2003;26:1932–9.PubMedCrossRef
11.
Holmes GK. Coeliac disease and Type 1 diabetes mellitus - the case for screening. Diabetes Med. 2001;18:169–77.CrossRef
12.
Valerio G, Maiuri L, Troncone R, Buono P, Lombardi F, et al. Severe clinical onset of diabetes and increased prevalence of other autoimmune diseases in children with coeliac disease diagnosed before diabetes mellitus. Diabetologia. 2002;45:1719–22.PubMedCrossRef
13.
Ventura A, Neri E, Ughi C, Leopaldi A, Citta A, et al. Gluten-dependent diabetes-related and thyroid-related autoantibodies in patients with celiac disease. J Pediatr. 2000;137:263–5.PubMedCrossRef
14.
Narula P, Porter L, Langton J, Rao V, Davies P, et al. Gastrointestinal symptoms in children with type 1 diabetes screened for celiac disease. Pediatrics. 2009;124:e489–95.PubMedCrossRef
15.
Cerutti F, Bruno G, Chiarelli F, Lorini R, Meschi F, et al. Younger age at onset and sex predict celiac disease in children and adolescents with type 1 diabetes: an Italian multicenter study. Diabetes Care. 2004;27:1294–8.PubMedCrossRef
16.
17.
Damen GM, Boersma B, Wit JM, Heymans HS. Catch-up growth in 60 children with celiac disease. J Pediatr Gastroenterol Nutr. 1994;19:394–400.PubMedCrossRef
18.
Kordonouri O, Maguire AM, Knip M, Schober E, Lorini R, et al. ISPAD Clinical Practice Consensus Guidelines 2006-2007. Other complications and associated conditions. Pediatr Diabetes. 2007;8:171–6.PubMedCrossRef
19.••
Husby S, Koletzko S, Korponay-Szabo IR, Mearin ML, Phillips A, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54:136–60. Society guidelines on screening and diagnosis of celiac disease recommending screening of patients with type 1 diabetes.PubMedCrossRef
20.
Leffler DA, Schuppan D. Update on serologic testing in celiac disease. Am J Gastroenterol. 2010;105:2520–4.PubMedCrossRef
21.••
Waisbourd-Zinman O, Hojsak I, Rosenbach Y, Mozer-Glassberg Y, Shalitin S, et al. Spontaneous normalization of anti-tissue transglutaminase antibody levels is common in children with type 1 diabetes mellitus. Dig Dis Sci. 2012;57:1314–20. Recent study that found over 30% of type 1 diabetes patients normalize celiac disease serologies while on a gluten free diet.PubMedCrossRef
22.
Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology. 2006;131:1981–2002.PubMedCrossRef
23.
Chand N, Mihas AA. Celiac disease: current concepts in diagnosis and treatment. J Clin Gastroenterol. 2006;40:3–14.PubMedCrossRef
24.
Miranda J, Lasa A, Bustamante MA, Churruca I, Simon E. Nutritional differences between a gluten-free diet and a diet containing equivalent products with gluten. Plant Foods Hum Nutr. 2014;69(2):182–187.
25.••
Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108:656–76. quiz 677. American society guidelines for screening and diagnosis of celiac disease recommending active case finding of celiac disease in individuals with type 1 diabetes.PubMedCentralPubMedCrossRef
26.
Bakker SF, Pouwer F, Tushuizen ME, Hoogma RP, Mulder CJ, et al. Compromised quality of life in patients with both Type 1 diabetes mellitus and coeliac disease. Diabetes Med. 2013;30:835–9.CrossRef
27.••
Mollazadegan K, Sanders DS, Ludvigsson J, Ludvigsson JF. Long-term coeliac disease influences risk of death in patients with type 1 diabetes. J Intern Med. 2013;274:273–80. This large Swedish study found with both celiac and type 1 diabetes in patients with >15 years of diabetes increases risk of death 2.8 fold.PubMedCrossRef
28.
Leeds JS, Hopper AD, Hadjivassiliou M, Tesfaye S, Sanders DS. High prevalence of microvascular complications in adults with type 1 diabetes and newly diagnosed celiac disease. Diabetes Care. 2011;34:2158–63.PubMedCentralPubMedCrossRef
29.
Amin R, Murphy N, Edge J, Ahmed ML, Acerini CL, et al. A longitudinal study of the effects of a gluten-free diet on glycemic control and weight gain in subjects with type 1 diabetes and celiac disease. Diabetes Care. 2002;25:1117–22.PubMedCrossRef
30.
Scaramuzza AE, Mantegazza C, Bosetti A, Zuccotti GV. Type 1 diabetes and celiac disease: the effects of gluten free diet on metabolic control. World J Diabetes. 2013;4:130–4.PubMedCentralPubMedCrossRef
31.
Krolewski AS, Warram JH, Rand LI, Kahn CR. Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med. 1987;317:1390–8.PubMedCrossRef
32.•
Noble JA, Erlich HA. Genetics of type 1 diabetes. Cold Spring Harb Perspect Med. 2012;2:a007732. Up-to-date review of genetic discoveries in type 1 diabetes.PubMedCentralPubMedCrossRef
33.
Hermann R, Turpeinen H, Laine AP, Veijola R, Knip M, et al. HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families. Tissue Antigens. 2003;62:162–9.PubMedCrossRef
34.
Sollid LM, Jabri B. Is celiac disease an autoimmune disorder? Curr Opin Immunol. 2005;17:595–600.PubMedCrossRef
35.•
Kumar V, Wijmenga C, Withoff S. From genome-wide association studies to disease mechanisms: celiac disease as a model for autoimmune diseases. Semin Immunopathol. 2012;34:567–80. Recent review on genetic associations in celiac and type 1 diabetes.PubMedCentralPubMedCrossRef
36.
Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med. 2008;359:2767–77.PubMedCentralPubMedCrossRef
37.•
Knip M, Simell O. Environmental triggers of type 1 diabetes. Cold Spring Harb Perspect Med. 2012;2:a007690. Recent review of environmental risk factors in type 1 diabetes.PubMedCentralPubMedCrossRef
38.
Kupfer SS, Jabri B. Pathophysiology of celiac disease. Gastrointest Endosc Clin N Am. 2012;22:639–60.PubMedCrossRef
39.
Norris JM, Barriga K, Klingensmith G, Hoffman M, Eisenbarth GS, et al. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA. 2003;290:1713–20.PubMedCrossRef
40.
Ziegler AG, Schmid S, Huber D, Hummel M, Bonifacio E. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA. 2003;290:1721–8.PubMedCrossRef
41.
Norris JM, Barriga K, Hoffenberg EJ, Taki I, Miao D, et al. Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA. 2005;293:2343–51.PubMedCrossRef
42.
Virtanen SM, Knip M. Nutritional risk predictors of beta cell autoimmunity and type 1 diabetes at a young age. Am J Clin Nutr. 2003;78:1053–67.PubMed
43.
Akobeng AK, Ramanan AV, Buchan I, Heller RF. Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies. Arch Dis Child. 2006;91:39–43.PubMedCentralPubMedCrossRef
44.
Yeung WC, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ. 2011;342:d35.PubMedCentralPubMedCrossRef
45.
Stene LC, Oikarinen S, Hyoty H, Barriga KJ, Norris JM, et al. Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY). Diabetes. 2010;59:3174–80.PubMedCentralPubMedCrossRef
46.
Stene LC, Honeyman MC, Hoffenberg EJ, Haas JE, Sokol RJ, et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol. 2006;101:2333–40.PubMedCrossRef
47.
Zanoni G, Navone R, Lunardi C, Tridente G, Bason C, et al. In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes. PLoS Med. 2006;3:e358.PubMedCentralPubMedCrossRef
48.
49.
50.
von Herrath MG, Fujinami RS, Whitton JL. Microorganisms and autoimmunity: making the barren field fertile? Nat Rev Microbiol. 2003;1:151–7.CrossRef
51.
Rook GA, Adams V, Hunt J, Palmer R, Martinelli R, et al. Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders. Springer Semin Immunopathol. 2004;25:237–55.PubMedCrossRef
52.
Vaarala O, Atkinson MA, Neu J. The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes. 2008;57:2555–62.PubMedCentralPubMedCrossRef
53.•
Atkinson MA, Chervonsky A. Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease. Diabetologia. 2012;55:2868–77. Recent review of the gut microbiome and development of type 1 diabetes.PubMedCentralPubMedCrossRef
54.
55.
McInerney MF, Pek SB, Thomas DW. Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice. Diabetes. 1991;40:715–25.PubMedCrossRef
56.
Satoh J, Shintani S, Oya K, Tanaka S, Nobunaga T, et al. Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats. Diabetes. 1988;37:1188–94.PubMedCrossRef
57.
Valladares R, Sankar D, Li N, Williams E, Lai KK, et al. Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS One. 2010;5:e10507.PubMedCentralPubMedCrossRef
58.
Lau K, Benitez P, Ardissone A, Wilson TD, Collins EL, et al. Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias. J Immunol. 2011;186:3538–46.PubMedCrossRef
59.
Markle JG, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science. 2013;339:1084–88.PubMedCrossRef
60.
Lee AS, Gibson DL, Zhang Y, Sham HP, Vallance BA, et al. Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice. Diabetologia. 2010;53:741–8.PubMedCrossRef
61.••
Marietta EV, Gomez AM, Yeoman C, Tilahun AY, Clark CR, et al. Low incidence of spontaneous type 1 diabetes in non-obese diabetic mice raised on gluten-free diets is associated with changes in the intestinal microbiome. PLoS One. 2013;8:e78687. Marietta and colleagues compared the effect of feeding a gluten free diet and gluten containing diet on the microbiome and incidence of hyperglycemia in NOD mice and found a reduced rate of hyperglycemia while on the gluten free diet.PubMedCentralPubMedCrossRef
62.
Soyucen E, Gulcan A, Aktuglu-Zeybek AC, Onal H, Kiykim E, et al. Differences in the gut microbiota of healthy children and those with type 1 diabetes. Pediatr Int. 2013;56(3):336–343.
63.
64.
de Goffau MC, Luopajarvi K, Knip M, Ilonen J, Ruohtula T, et al. Fecal microbiota composition differs between children with beta-cell autoimmunity and those without. Diabetes. 2013;62:1238–44.PubMedCentralPubMedCrossRef
65.
Murri M, Leiva I, Gomez-Zumaquero JM, Tinahones FJ, Cardona F, et al. Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med. 2013;11:46.PubMedCentralPubMedCrossRef
66.
Laparra JM, Olivares M, Gallina O, Sanz Y. Bifidobacterium longum CECT 7347 modulates immune responses in a gliadin-induced enteropathy animal model. PLoS One. 2012;7:e30744.PubMedCentralPubMedCrossRef
67.
Papista C, Gerakopoulos V, Kourelis A, Sounidaki M, Kontana A, et al. Gluten induces coeliac-like disease in sensitised mice involving IgA, CD71 and transglutaminase 2 interactions that are prevented by probiotics. Lab Invest. 2012;92:625–35.PubMedCrossRef
68.
D'Arienzo R, Stefanile R, Maurano F, Mazzarella G, Ricca E, et al. Immunomodulatory effects of Lactobacillus casei administration in a mouse model of gliadin-sensitive enteropathy. Scand J Immunol. 2011;74:335–41.PubMedCrossRef
69.
Cinova J, De Palma G, Stepankova R, Kofronova O, Kverka M, et al. Role of intestinal bacteria in gliadin-induced changes in intestinal mucosa: study in germ-free rats. PLoS One. 2011;6:e16169.PubMedCentralPubMedCrossRef
70.
Sanchez E, Donat E, Ribes-Koninckx C, Fernandez-Murga ML, Sanz Y. Duodenal-mucosal bacteria associated with celiac disease in children. Appl Environ Microbiol. 2013;79:5472–9.PubMedCentralPubMedCrossRef
71.
Sanchez E, Ribes-Koninckx C, Calabuig M, Sanz Y. Intestinal Staphylococcus spp. and virulent features associated with coeliac disease. J Clin Pathol. 2012;65:830–4.PubMedCrossRef
72.
Collado MC, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J Clin Pathol. 2009;62:264–9.PubMedCrossRef
73.
Nadal I, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J Med Microbiol. 2007;56:1669–74.PubMedCrossRef
74.
De Palma G, Nadal I, Medina M, Donat E, Ribes-Koninckx C, et al. Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children. BMC Microbiol. 2010;10:63.PubMedCentralPubMedCrossRef
75.
Cheng J, Kalliomaki M, Heilig HG, Palva A, Lahteenoja H, et al. Duodenal microbiota composition and mucosal homeostasis in pediatric celiac disease. BMC Gastroenterol. 2013;13:113.PubMedCentralPubMedCrossRef
76.
Wacklin P, Kaukinen K, Tuovinen E, Collin P, Lindfors K, et al. The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease. Inflamm Bowel Dis. 2013;19:934–41.PubMedCrossRef
77.
Schippa S, Iebba V, Barbato M, Di Nardo G, Totino V, et al. A distinctive 'microbial sigNature.' in celiac pediatric patients. BMC Microbiol. 2010;10:175.PubMedCentralPubMedCrossRef
78.
Caminero A, Herran AR, Nistal E, Perez-Andres J, Vaquero L, et al. Diversity of the cultivable human gut microbiome involved in gluten metabolism: isolation of microorganisms with potential interest for coeliac disease. FEMS Microbiol Ecol. 2014;88(2):309–319.
79.
Sanchez E, Nadal I, Donat E, Ribes-Koninckx C, Calabuig M, et al. Reduced diversity and increased virulence-gene carriage in intestinal enterobacteria of coeliac children. BMC Gastroenterol. 2008;8:50.PubMedCentralPubMedCrossRef
80.
Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;139:485–98.PubMedCentralPubMedCrossRef
81.
Gaboriau-Routhiau V, Rakotobe S, Lecuyer E, Mulder I, Lan A, et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity. 2009;31:677–89.PubMedCrossRef
82.
Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature. 2008;455:1109–13.PubMedCentralPubMedCrossRef
83.
Sorini C, Falcone M. Shaping the (auto)immune response in the gut: the role of intestinal immune regulation in the prevention of type 1 diabetes. Am J Clin Exp Immunol. 2013;2:156–71.PubMedCentralPubMed
84.
Fernandez S, Molina IJ, Romero P, Gonzalez R, Pena J, et al. Characterization of gliadin-specific Th17 cells from the mucosa of celiac disease patients. Am J Gastroenterol. 2011;106:528–38.PubMedCrossRef
85.
Boudraa G, Hachelaf W, Benbouabdellah M, Belkadi M, Benmansour FZ, et al. Prevalence of coeliac disease in diabetic children and their first- degree relatives in west Algeria: screening with serological markers. Acta Paediatr. 1996;412(Suppl):58–60.CrossRef
86.
Peretti N, Bienvenu F, Bouvet C, Fabien N, Tixier F, et al. The temporal relationship between the onset of type 1 diabetes and celiac disease: a study based on immunoglobulin a antitransglutaminase screening. Pediatrics. 2004;113:e418–22.PubMedCrossRef
87.
Mahmud FH, Murray JA, Kudva YC, Zinsmeister AR, Dierkhising RA, et al. Celiac disease in type 1 diabetes mellitus in a North American community: prevalence, serologic screening, and clinical features. Mayo Clin Proc. 2005;80:1429–34.PubMedCentralPubMedCrossRef
88.
Frohlich-Reiterer EE, Hofer S, Kaspers S, Herbst A, Kordonouri O, et al. Screening frequency for celiac disease and autoimmune thyroiditis in children and adolescents with type 1 diabetes mellitus—data from a German/Austrian multicentre survey. Pediatr Diabetes. 2008;9:546–53.PubMedCrossRef
89.
Salardi S, Volta U, Zucchini S, Fiorini E, Maltoni G, et al. Prevalence of celiac disease in children with type 1 diabetes mellitus increased in the mid-1990s: an 18-year longitudinal study based on anti-endomysial antibodies. J Pediatr Gastroenterol Nutr. 2008;46:612–4.PubMedCrossRef
90.
Uibo O, Heilman K, Rago T, Shor R, Paal M, et al. Symptomless celiac disease in type 1 diabetes: 12-year experience in Estonia. Pediatr Int. 2010;52:230–3.PubMedCrossRef
91.
Fallahi GH, Ahmadian JH, Rabbani A, Yousefnezhad AS, Rezaei N. Screening for celiac disease in diabetic children from Iran. Indian Pediatr. 2010;47:268–70.PubMedCrossRef
92.
Djuric Z, Stamenkovic H, Stankovic T, Milicevic R, Brankovic L, et al. Celiac disease prevalence in children and adolescents with type 1 diabetes from Serbia. Pediatr Int. 2010;52:579–83.PubMedCrossRef
93.
Bhadada SK, Kochhar R, Bhansali A, Dutta U, Kumar PR, et al. Prevalence and clinical profile of celiac disease in type 1 diabetes mellitus in north India. J Gastroenterol Hepatol. 2011;26:378–81.PubMedCrossRef
94.
Hanukoglu A, Mizrachi A, Dalal I, Admoni O, Rakover Y, et al. Extrapancreatic autoimmune manifestations in type 1 diabetes patients and their first-degree relatives: a multicenter study. Diabetes Care. 2003;26:1235–40.PubMedCrossRef
95.
Sari S, Yesilkaya E, Egritas O, Bideci A, Cinaz P, et al. Prevalence of Celiac disease in Turkish children with type 1 diabetes mellitus and their non-diabetic first-degree relatives. Turk J Gastroenterol. 2010;21:34–8.PubMed
96.••
van der Windt DA, Jellema P, Mulder CJ, Kneepkens CM, van der Horst HE. Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. JAMA. 2010;303:1738–46. Excellent review of diagnostic testing strategies for celiac disease.PubMedCrossRef
Metadata
Title
Type 1 Diabetes and Celiac Disease: Clinical Overlap and New Insights into Disease Pathogenesis
Authors
Aaron Cohn
Anthony M. Sofia
Sonia S. Kupfer
Publication date
01-08-2014
Publisher
Springer US
Published in
Current Diabetes Reports / Issue 8/2014
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-014-0517-x

Other articles of this Issue 8/2014

Current Diabetes Reports 8/2014 Go to the issue

Obesity (J McCaffery, Section Editor)

Obesity and Type 2 Diabetes in Children: Epidemiology and Treatment

Transplantation (A Pileggi, Section Editor)

Autologous Islet Transplantation in Patients Requiring Pancreatectomy for Neoplasm

Microvascular Complications—Retinopathy (JK Sun, Section Editor)

Ultra Widefield Fundus Imaging for Diabetic Retinopathy

Diabetes and Other Diseases-Emerging Associations (JJ Nolan, Section Editor)

Cystic Fibrosis Related Diabetes

Microvascular Complications—Nephropathy (B Roshan, Section Editor)

Novel Urinary Biomarkers in Early Diabetic Kidney Disease

Microvascular Complications—Nephropathy (B Roshan, Section Editor)

Resistant Hypertension in Diabetes Mellitus
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits